🤖AI Newsletter
September 24, 2026 · 10:32 Uhr
1Anthropic: Claude discovers unknown enzyme system in bacteriophages
@AnthropicAI Claude independently identified a previously unknown enzyme system in bacteriophage DNA – a genuine scientific breakthrough without human groundwork. This marks a quality leap: AI now performs original research, not just assistance. The discovery has potentially massive implications for biotech, pharma, and the question of how far autonomous AI systems should be deployed in science.
2Gemini 4: Google DeepMind launches post-training for flagship model
@TheLatentCo DeepMind CEO Koray Kavukcuoglu confirms that Gemini 4 has entered early post-training phase and is slated for release before year-end. This significantly intensifies the race for the most powerful AI model – especially since Polymarket currently rates Anthropic as leading with 99% probability. A strong Gemini 4 could fundamentally shift market dynamics among enterprise customers and developers.
3Anthropic IPO: Polymarket sees 78% chance of September public offering
Polymarket Prediction markets value an Anthropic IPO by end of September 2026 at 78% probability, despite the October bet collapsing by nearly 70% in the same month. An Anthropic public debut would be the year's most significant tech IPO and would set the valuation benchmark for the entire AI ecosystem. Uncertainty about timing and valuation creates significant volatility in institutional investor expectations.
4Deel AKAI: Enterprise agent achieves $140M ARR in 90 days
@VadimStrizheus Deel, valued at $17B, achieved $140M ARR with its AI agent AKAI in just 90 days – proof that autonomous workflow automation is immediately monetizable at enterprise level. The approach of fully replacing HR and office processes with AI agents signals the next step beyond copilot features. This could become a benchmark for other SaaS providers and massively increase pressure on traditional software vendors.
5S&P 500: AI boom drives 32% earnings growth – earnings supercycle
@DeItaone Wall Street expects S&P 500 earnings growth of 32% in the current year, primarily driven by AI investments and beat quarterly results, according to current estimates. JPMorgan's Gabriela Santos confirms to CNBC that AI buildout is actively fueling the earnings supercycle. This supports the thesis that AI ROI is now measurably translating to broad enterprise level – contradicting the productivity paradox debate at the individual level.
Situation Report
September 2026 marks a turning point: AI systems deliver original scientific performance for the first time (Claude/enzyme discovery, OpenAI/Navier-Stokes), while competition for model leadership enters the next round with Gemini 4, and Anthropic is rated as the currently strongest lab with 99% probability. Economic penetration is accelerating rapidly – Deel's $140M ARR in 90 days and S&P 500 earnings growth of 32% demonstrate that AI ROI is now tangible at enterprise level. Simultaneously, the geopolitical tension field is growing: China's Alibaba dominates the Chinese AI market with 92% market estimate, while Mistral invests €3B in European AI sovereignty. A potential Anthropic IPO with 78% probability of occurrence could redefine global AI valuation benchmarks and draw institutional capital into the sector on an unprecedented scale.
Tokens: 2,226(1,383 in · 843 out)